The 12th ‘Utrecht Sessions’: The Pulmonary Valve

We are very pleased with the many positive responses from speakers and chairpersons. The final programme with speaker details will follow as soon as all speakers have confirmed. Below is the preliminary version of the programme.

Friday February 5th

08.00 – 08.30 – Registration and coffee
08.30 – 08.45 – Welcome
Gregor Krings and Bram van Wijk

Pulmonary Valve disease: the beginnings

Chairpersons: follows

08.45 – 09.10 – Development of the pulmonary valve
09.10 – 09.35 – Fetal imaging
09.35 – 10.00 – Postnatal imaging
10.00 – 10.25 – PV and genetics: is there more?
10.25 – 10.50 – Case based: strategy on pulmonary valve stenosis in fetal life
10.50 – 11.20 – Coffee break

First interventions in Pulmonary Valve disease

Chairpersons: follows

11.20 – 11.40 – Surgery on the pulmonary valve in the newborn and infant
11.40 – 12.00 – Catheter interventions postnatally from valvuloplasty to RVOT stenting
12.00 – 12.20 – Strategy in PA IVS with borderline RV
12.20 – 12.35 – Pro/Con RVOT stent in the neonate: Interventionalist
12.35 – 12.50 – Pro/Con RVOT stent in the neonate: Surgeon
12.50 – 13.10 – Pro/Con discussion
13.10 – 14.00 – Meet, greet, and eat

Pulmonary Valve and the RV: time is ticking

Chairpersons: follows

14.00 – 14.20 – Visualising und understanding PV and branches after first intervention
14.20 – 14.45 – Sister from another mister: the RV is no LV
14.45 – 15.05 – Mechanisms and assessment of RV adaption
15.05 – 15.25 – Are current guidelines adequate for clinical decision making?
15.25 – 15.45 – To valve or not to valve
15.45 – 16.10 – Tea break

Battle: calcified conduit and severe PI

Chairpersons: follows

16.10 – 16.30 – Case 1: calcified conduit
16.30 – 17.00 – Battle Re-homograft vs PPVI
17.00 – 17.20 – Case 2: large/native RVOT
17.20 – 17.50 – Battle first grafts vs PPVI
17.50 – 18.15 – Discussion: panel + audience
18.15 – 18.20 – Closing remarks

Saturday February 6th

08.45 – 08.50 – Welcome
Trinette Steenhuis and Bram van Wijk

Pulmonary Valve: Strategy Part I

Chairpersons: follows

08.50 – 09.15 – Portfolio of surgical valves
09.15 – 09.40 – Severe PV dysplasia: when and how to reconstruct
09.40 – 10.00 – PPVI for calcified conduits and more foreign positions
10.00 – 10.25 – PPVI in large RVOT: current options and limitations
10.25 – 10.50 – PV endocarditis: understand, prevent and treat
10.50 – 11.20 – Coffee break

Pulmonary Valve: Strategy Part II

11.20 – 11.45 – Best of two worlds: hybrid approach
11.45 – 12.10 – Bifurcation stenosis and pulmonary valve function: an engineering perspective
12.10 – 12.30 – Arrhythmia management in the context of PV dysfunction
12.30 – 12.50 – Long-term outcomes and lifetime management of PVR
12.50 – 13.10 – Partial heart transplantations: a real option for the PV?
13.10 – 13.50 – Meet, great and eat

Pulmonary Valve: Innovations

Chairpersons: follows

13.50 – 14.10 – Gore valved conduit and Autus valve
14.10 – 14.30 – Immune shielded heart valve implant: homograft reactor
14.30 – 14.50 – Valvulogenesis of a living, innervated pulmonary root induced by an acellular scaffold
14.50 – 15.10 – Creating a PV from the right atrial appendage
15.10 – 15.30 – Percutaneous valves: next generation PPVI starting fetal
15.30 – 15.45 – Wrap up, EBAC evaluation and closing remarks